triiodothyronine has been researched along with Hyperhomocysteinemia in 4 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperhomocysteinemia is a risk factor for premature atherosclerotic vascular disease and venous thrombosis." | 7.72 | Plasma homocysteine concentrations in adolescents with subclinical hypothyroidism. ( Atabek, ME; Erkul, I; Pirgon, O, 2003) |
| "Controversy remains as to the risk of cardiovascular disease (CVD) associated with subclinical hypothyroidism (SCH), defined as an increased serum thyrotropin (TSH) concentration with normal free thyroxine and triiodothyronine levels." | 4.84 | Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? ( Duntas, LH; Wartofsky, L, 2007) |
| "Hyperhomocysteinemia is a risk factor for premature atherosclerotic vascular disease and venous thrombosis." | 3.72 | Plasma homocysteine concentrations in adolescents with subclinical hypothyroidism. ( Atabek, ME; Erkul, I; Pirgon, O, 2003) |
| "Hyperhomocysteinemia is a risk factor for cardiovascular diseases, while tissue factor pathway inhibitor (TFPI) regulates the extrinsic pathway of blood coagulation." | 1.33 | Elevated TFPI levels in female hyperhomocysteinemic patients. ( Götting, C; Kleesiek, K; Siegling, S; Thyzel, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Wang, Q | 1 |
| Li, Q | 1 |
| Lu, P | 1 |
| Atabek, ME | 1 |
| Pirgon, O | 1 |
| Erkul, I | 1 |
| Thyzel, E | 1 |
| Siegling, S | 1 |
| Götting, C | 1 |
| Kleesiek, K | 1 |
| Duntas, LH | 1 |
| Wartofsky, L | 1 |
1 review available for triiodothyronine and Hyperhomocysteinemia
| Article | Year |
|---|---|
Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation Disorders; Cardiovascular Diseases; Humans; Hyperc | 2007 |
1 trial available for triiodothyronine and Hyperhomocysteinemia
| Article | Year |
|---|---|
Association between Hyperhomocysteinemia and Thyroid Hormones in Euthyroid Diabetic Subjects.
Topics: Adult; Aged; Atherosclerosis; Cross-Sectional Studies; Diabetes Complications; Female; Humans; Hyper | 2015 |
2 other studies available for triiodothyronine and Hyperhomocysteinemia
| Article | Year |
|---|---|
Plasma homocysteine concentrations in adolescents with subclinical hypothyroidism.
Topics: Adolescent; Cholesterol; Fasting; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hy | 2003 |
Elevated TFPI levels in female hyperhomocysteinemic patients.
Topics: Adult; Aged; Biomarkers; Blood Donors; Female; Humans; Hyperhomocysteinemia; Lipoproteins; Male; Mid | 2005 |